Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • "Complete" remission in chronic lymphocytic leukemia (CLL) is strongly affected by the use of CT scanning: Results from a prospective randomized trial of fludarabine plus cyclophosphamide (Flu/Cy) with or without genasense (Oblimersen) in patients with relapsed or refractory disease
    Meeting Abstract

    Maslak, P.; Caravelli, J.; Chanan-Khan, A. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • LRF/Pokemon plays a pivotal role in B versus T lymphoid lineage fate decision at the early lymphoid progenitor stage by opposing Notch1 signaling
    Meeting Abstract

    Maeda, T.; Merghoub, T.; Dong, L.; Maeda, M.; Hobbs, R.; Zakrzewski, J.; Van Den Brink, M.; Shigematsu, H.; Akashi, K.; Zelent, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • T-cell signaling in allogeneic bone marrow transplantation
    Meeting Abstract

    Lu, S. X.; Chow, M. Y.; Hubbard, V. M.; Suh, D. Y.; Kim, T. D.; Kochman, A.; Zakrzewski, J.; Cabrera-Perez, J.; Alpdogan, O.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Circulating tumor cells of prostatic adenocarcinoma: Cytomorphologic findings
    Meeting Abstract

    Lin, O.; Reuter, V. E.; Shaffer, D.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Circulating tumor cells of prostatic adenocarcinoma: Cytomorphologic findings
    Meeting Abstract

    Lin, O.; Reuter, V. E.; Shaffer, D.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Urothelial carcinomas of the renal pelvis. Sensitivity of instrumented and voided urine
    Meeting Abstract

    Lin, O.; Olgac, S.; Bochner, B.; Dalbagni, G.; Reuter, V. E.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • Urothelial carcinomas of the renal pelvis. Sensitivity of instrumented and voided urine
    Meeting Abstract

    Lin, O.; Olgac, S.; Bochner, B.; Dalbagni, G.; Reuter, V. E.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Preliminary results of concurrent chemotherapy with intensity-modulated radiation therapy (IMRT) for advanced cancer of the larynx/hypopharynx
    Meeting Abstract

    Lee, N.; Chan, K.; Zhung, J.; Wolden, S.; Su, Y. B.; Kraus, D.; Singh, B.; Shaha, A.; Shah, J.; Pfister, D. G.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save